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NMRCell penetrating peptides (CPPs) are peptides displaying the ability to cross cell membranes and transport
cargo molecules inside cells. Several uptake mechanisms (endocytic or direct translocation through the
membrane) are being considered, but the interaction between the CPP and the cell membrane is certainly a
preliminary key point to the entry of the peptide into the cell. In this study, we used three basic peptides: RL9
(RRLLRRLRR-NH2), RW9 (RRWWRRWRR-NH2) and R9 (RRRRRRRRR-NH2). While RW9 and R9 were
internalised into wild type Chinese Hamster Ovary cells (CHO) and glycosaminoglycan-deﬁcient CHO cells,
at 4 °C and 37 °C, RL9 was not internalised into CHO cells. To better understand the differences between RW9,
R9 and RL9 in terms of uptake, we studied the interaction of these peptides with model lipid membranes. The
effect of the three peptides on the thermotropic phase behaviour of a zwitterionic lipid (DMPC) and an anionic
lipid (DMPG) was investigated with differential scanning calorimetry (DSC). The presence of negative charges
on the lipid headgroups appeared to be essential to trigger the peptide/lipid interaction. RW9 and R9
disturbed the main phase transition of DMPG, whereas RL9 did not induce signiﬁcant effects. Isothermal
titration calorimetry (ITC) allowed us to study the binding of these peptides to large unilamellar vesicles
(LUVs). RW9 and R9 proved to have about ten fold more afﬁnity for DSPG LUVs than RL9. With circular
dichroism (CD) and NMR spectroscopy, the secondary structure of RL9, RW9 and R9 in aqueous buffer or lipid/
detergent conditions was investigated. Additionally, we tested the antimicrobial activity of these peptides
against Escherichia coli and Staphylococcus aureus, as CPPs and antimicrobial peptides are known to share
several common characteristics. Only RW9 was found to be mildly bacteriostatic against E. coli. These studies
helped us to get a better understanding as to why R9 and RW9 are able to cross the cell membrane while RL9
remains bound to the surface without entering the cell.ular dichroism; CHO, Chinese
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For the past 15 years, cell penetrating peptides (CPPs) have
attracted much attention. Indeed, their unique ability to cross the
plasma membrane designates them as potentially very powerful
vectors to transport molecules that would otherwise never penetrate
into cells such as heavily negatively charged polynucleic acids or
some small molecules with therapeutic interest [1]. Since the dis-
covery of penetratin, the third helix of the Antennapedia home-
odomain [2,3], and of the HIV Tat peptide [4,5] in the 1990s, there has
been extensive work to develop new synthetic and powerful CPPs
such as polyarginines [6,7]. Many of these peptides share common
features, namely a high density in basic residues and an amphipathic
secondary structure in membrane environments. Together with the
design of new peptides, there has been massive investigation on the
internalisation mechanisms of CPPs. Indeed, a good understanding of
the internalisation routes is essential for the development of efﬁcient
vectors. Cellular uptake mechanism is highly controversial, and both
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discussed. Independently from their internalisation mechanisms, the
interaction between the CPP and the cell membrane should be a
preliminary key point to be taken into account. In this perspective, the
study of the interaction of peptides with model lipid membranes can
provide precious information about the phenomena that may occur at
the cell surface. Cellular membranes can be simulated by very simple
objects such as detergent micelles or lipid monolayers, or by more
complex models such as multi-lamellar vesicles (MLVs) or large uni-
lamellar vesicles (LUVs). The diversity of membrane models gives
access to a very large array of biophysical techniques to study peptide/
lipid interactions.
In this study, we chose to investigate the membrane behaviour of
three arginine-rich peptides: the well known nona-arginine R9 peptide
(RRRRRRRRR-NH2) and two amphipathic peptideswith a similar charge
distribution, RW9 (RRWWRRWRR-NH2) and RL9 (RRLLRRLRR-NH2).
The RW9 and RL9 peptides derive from the 16-mer sequences RW16
(RRWRRWWRRWWRRWRR-NH2) andRL16 (RRLRRLLRRLLRRLRR-NH2)
respectively,whichweredesigned frompenetratin [8]. The three studied
peptides RW9, RL9 and R9 share a common high density of arginine
residues, which confers nine positive charges to R9 and six positive
charges to RW9 and RL9.
It is well established that polyarginines such as R9 are very
potent CPPs [6]. Different studies also showed that RW9 is efﬁciently
internalised into cells [9,10]. Surprisingly, we found, using mass
spectrometry quantiﬁcation methods [11], that RL9 is very poorly
internalised by cells. Therefore, the behaviour of these three peptides
was studied in the presence of membrane models (MLVs and LUVs) in
an attempt to correlate their different cellular uptake with a distinct
behaviour at the level of lipid/peptide interactions. Herein, the
thermodynamics of peptide interaction with lipid model systems
was investigated, both in terms of afﬁnity and peptide induced
perturbation of the lipid phase transition using isothermal titration
calorimetry (ITC) and differential scanning calorimetry (DSC),
respectively. Additionally, the peptide structural changes accompa-
nying lipid interactionweremonitored by circular dichroism (CD) and
NMR spectroscopy. Finally, since CPPs and antimicrobial peptides
share common features [12], the antimicrobial activities of these
peptides were investigated against Escherichia coli and Staphylococcus
aureus.
2. Materials and methods
2.1. Materials
DMPC, DMPG and DSPGwere obtained as a powder from Genzyme
(Switzerland). DiPoPE and D8PG were purchased from Avanti Polar
Lipids (Alabaster, AL). DPC-d38 was purchased from Eurisotop (Saint-
Aubin, France). Biot(O2)-Apa-RW9, Biot(O2)-Apa-R9, Biot-(Gly)4-RL9
and Biot-([2,2-D2]-Gly)4-RL9 were obtained from PolyPeptide Labo-
ratories (Strasbourg, France). Biot(O2)-Apa-RL9, Biot(O2)-(Gly)4-
RW9 and Biot(O2-([2,2-D2]-Gly)4-RW9 were synthesised using the
Boc-solid phase strategy. Peptides used in most experiments have the
Biot(O2)-Apa N-terminal extension, except in quantiﬁcation studies
where the peptides have the Biot(O2)-(Gly)4 N-terminal extension
(Section 2.4).
2.2. Cell culture
Wild type Chinese Hamster Ovary CHO-K1 cells and xylose
transferase-deﬁcient CHO-pgsA745 cells were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% foetal calf
serum (FCS), penicillin (100,000 IU/L), streptomycin (100,000 IU/L),
and amphotericin B (1 mg/L) in a humidiﬁed atmosphere containing
5% CO2 at 37 °C.2.3. Cytotoxicity and membrane integrity
Cytotoxicity was measured using the Dojindo Cell-Counting Kit
8 based on the reduction of a reagent into a coloured product by viable
cell dehydrogenases. CHO-K1 cells were seeded in a 96-well plate
1 day before treatment (4000 cells per well). Cells were treated with
0.1 μM, 1 μM, 5 μM and 20 μM peptide for 1 h, 3 h, 6 h, 16 h and 24 h.
Untreated cells were deﬁned as zero (negative control), and 1% SDS as
maximum cytotoxicity (positive control).
Membrane perturbationwasmeasured using the Promega CytoTox-
ONE kit based on the quantiﬁcation of lactate dehydrogenase (LDH)
leakage. CHO-K1 cells were seeded in a 96-well plate (10,000 cells per
well) 1 day before treatment. The same conditions as for cytotoxicity
assays were used. Maximum LDH release was induced by treatment
with 0.2% Triton X-100.
2.4. Measure of cellular uptake and quantiﬁcation of membrane-bound
peptide
Cellular uptakewasquantiﬁedusing themethoddescribed byBurlina
et al [13]. In this protocol, the studied peptide bears a tag composed of
four glycine residues together with a biotin moiety for puriﬁcation
purposes. After 1 h incubation of 7.5 μMpeptide andwashing, a protease
is added (0.05% Pronase in Tris–HCl buffer, 100 mM pH 7.5) in order to
detach the cells and to degrade all the non-internalised or membrane-
bound peptide. This avoids overestimating the quantity of internalised
peptide due to the presence of peptides attached to the outer leaﬂet of
the membrane. The cells are then lysed (0.3% Triton) and boiled and the
cell lysate is then incubated with streptavidin-coated magnetic beads to
extract the peptide from the lysate. For membrane-bound peptide
quantiﬁcation, the same experimental conditions were used except that
no proteasewas added and the cellswere directly lysed. Thepeptides are
eluted from the streptavidin-coated magnetic beads with HCCA matrix
and spotted on theMALDI plate. Mass spectrometry is not a quantitative
method per se, therefore an internal standard is added to the lysis
solution. This standard peptide has the same sequence as the one to
quantify except that it bears a tag composed of four deuterated glycine
residues instead of four glycine residues. This allows the quantiﬁcation of
internalised and membrane-bound peptide. The samples were analysed
by MALDI-TOF MS (positive ion reﬂector mode) on a Voyager DEPRO
mass spectrometer (Applied Biosystems).
2.5. Antimicrobial activity
Gram-positive eubacteria (S. aureus RN4220) and Gram-negative
eubacteria (E. coli ML35p) were grown in Luria–Bertani (LB) broth at
37 °C. The minimal inhibitory concentrations (MICs) of peptides were
determined in 96-well microtitration plates by growing the bacteria
in the presence of 2-fold serial dilutions of peptide ranging from 0.2 to
100 μM. Aliquots (10 μL) of each serial dilution were incubated for
16 h at 37 °C with 90 μL of a suspension of a midlogarithmic phase
culture of bacteria at a starting absorbance A630=0.05 in Poor Broth
nutrient medium (1% Casein peptone and 1% NaCl, w/v). Growth
inhibition was assayed by measuring the absorbance at 630 nm. The
MIC was deﬁned as the lowest concentration of peptide that inhibited
the growth of 99% or more of the bacteria. 0% inhibition corresponded
to untreated bacteria (negative control), 100% inhibition corre-
sponded to bacteria treated with 0.2% formaldehyde (positive
control).
If a MIC could be determined, then 2 μL of the bacterial suspension
that was incubated with a concentration of peptide corresponding to
the MIC and the concentration just above the MIC were taken, plated
out on solid culture medium containing 1% noble agar and incubated
overnight at 37 °C. If the bacteria were able to re-grow, the peptide
was described as bacteriostatic, otherwise the peptide was described
as bacteriolytic.
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Lipid ﬁlms were made by dissolving the appropriate amount of
lipid into chloroform or a mixture of chloroform and methanol (2/1
vol/vol). The solvent was then evaporated under nitrogen to deposit
the lipid as a ﬁlm on thewall of a test tube. Final traces of solvent were
removed in a vacuum chamber attached to a liquid nitrogen trap
during 3–4 h. Films were then hydrated with 10 mM Tris, 0.1 M NaCl,
2 mM EDTA, pH 7.6 for DSC and ITC experiments. For CD experiments,
lipid ﬁlms were hydrated with 10 mM sodium phosphate buffer pH
7.6. The ﬁlms were then vortexed extensively at a temperature
superior to the phase transition temperature of the lipid to obtain
MLVs. To form LUVs, the MLVs were subjected to ﬁve freeze/thawing
cycles. For low concentration of lipids (~1 mg/mL), the homogeneous
lipid suspension was passed 19 times trough a mini-extruder (Avanti
Alabaster, AL) equipped with two stacked 100 nm polycarbonate
membranes at a temperature above the phase transition temperature
of the lipid. For higher concentrations of lipids (~10 mg/mL), the
homogeneous lipid suspensionwas passed 10 times trough a nitrogen
pressure driven extruder (LIPEX, Northern Lipids Inc., BC) equipped
with a 100 nm polycarbonate membrane at a temperature above the
phase transition temperature of the lipid.
2.7. Differential scanning calorimetry (DSC)
DSC experiments were performed on a high-sensitivity calorim-
eter (TA Instruments). A scan rate of 1 °C/min was used and there was
a delay of 10 min between sequential scans in a series to allow
thermal equilibration. Data analysis was performed by the ﬁtting
program NanoAnalyze provided by TA Instruments. The lipid
concentration was 1 mg/mL, except for experiments with DiPoPE
where a concentration of 10 mg/mL of lipid was used, due to the
weaker DSC signal displayed by this lipid. Biot(O2)-Apa-RL9, Biot(O2)-
Apa-RW9 or Biot(O2)-Apa-R9 were gradually added to the lipid MLVs
to obtain peptide/lipid molar ratios of 1/100, 1/50, 1/25 and 1/10,
except for experiments with DiPoPE where a peptide/lipid ratio of 1/
25 was used. A minimum of at least three to four heating and cooling
scans were performed for each analysis.
2.8. Isothermal titration calorimetry (ITC)
ITC experiments were performed on a TA Instrument nano ITC
calorimeter. To avoid air bubbles, peptide and LUVs solutions were
degassed under vacuum before use. Titrations were performed by
injecting aliquots of LUVs (lipid concentration varying between
12.48 mM and 6.24 mM) into the calorimeter cell containing the
peptide solution (peptide concentration 0.1 mM), with 5 min waiting
between injections. The experiments were performed at 25 °C. Data
analysis was performed using the program NanoAnalyze provided by
TA Instruments.
2.9. Turbidity measurements
Turbidity changes in LUVs and MLVs suspensions following
peptide addition (at P/L ratios of 1/100, 1/50, 1/25 and 1/10) were
monitored by absorbance measurement at 436 nm. Peptide was
gradually added to 500 μL of lipid LUVs/MLVs suspensions (at 1 mg/
mL of lipid) in 10 mMphosphate buffer. Absorbancewasmeasured on
a UVICON 930 spectrophotometer at room temperature.
2.10. Circular dichroism experiments
The CD spectra of the peptides were recorded on a Jobin Yvon CD6
dichrograph linked to a PCmicroprocessor. The spectra were recorded
at 25 °C in a quartz optical cell with a 1 mm path length from 185
to 260 nm with a 0.5-nm step. Four scans were accumulated andaveraged after buffer (or LUV) spectra subtraction and baseline
correction. The spectra were acquired for peptide concentrations
varying from28 μMto 127 μM(corresponding to peptide to lipid ratios
of 1/50 to 1/10) in phosphate buffer or in the presence of lipid LUVs
(1 mg/mL). CD measurements were reported as Δε (M−1 cm−1).
2.11. NMR spectroscopy
The peptide samples were prepared at 1 mM concentration in
550 μL of H2O/D2O (90:10 v/v) containing 50 mM sodium phosphate
at pH ~6. Sodium 2,2-dimethyl-2-silapentane-d6-5-sulfonate (DSS,
Isotec) was added (0.1 mM) for direct 1 H and indirect 13 C chemical
shift calibration. Micellar samples additionally contained 60 mMDPC-
d38 or 60 mM SDS, corresponding to a ratio of ~1 peptide per micelle.
Spectra of micellar samples were indirectly calibrated to the aqueous
samples due to interaction of DSS with the micelles.
NMR spectra were recorded on a Bruker Avance III spectrometer,
operating at a 1H frequency of 500.11 MHz, and equippedwith a triple-
resonance Z-gradient TCI cryoprobe. One-dimensional spectra were
recorded between 10 and 40 °C and 2D experiments were recorded at
20 or 35 °C. The following 2D experiments were recorded: TOCSY
(DIPSI-2 mixing sequence [14] with durations of 22 and 60 ms),
NOESY (mixing times of 50 and 125 ms) and natural abundance 1H–
13C HSQC. The solvent signal was suppressed using a WATERGATE
sequence and water ﬂip back pulses in homonuclear experiments
recorded on aqueous or micellar DPC samples [15,16]. For homonu-
clear experiments recorded on non-deuterated SDS samples, a double
pulsed ﬁeld gradient spin echo [17] was employed with selective
pulses centered on the amide/aromatic region (90° G4 shaped pulse of
4 ms and 180° RE-BURP shaped pulse of 3 ms). Gradient pulses were
used for coherence selection in HSQC experiments. Vicinal 3JHN-Hα
coupling constants weremeasured on 1D spectra for peptides in aque-
ous solutions. Coupling constants could not be measured in micellar
environments due to resonance broadening.
NMR data were processed and analysed with Bruker TOPSPIN 2.0
program. Time-domain data were typically apodised with shifted
sine-bell or squared sine-bell window functions, and zero-ﬁlled twice
prior to Fourier transformation. Indirect dimensions were extended
by linear prediction. Baseline distortions were corrected with a ﬁfth-
order polynomial function.
2.12. NMR structure calculations
Interproton distance restraints were estimated from NOESY cross-
peak volumes. The calibration was based on cross-peaks involving
aromatic Trp HNε1-Hζ2 protons (2.9 Å). For each peptide, a set of 50
structures was calculated by torsion angle dynamics in DYANA using
standard parameters [18]. The best 25 structures exhibiting the lowest
target function were then minimised using XPLOR-NIH program
[19]. CHARMM22 forceﬁeld was used and non-bond energy terms
consisted of a Lennard–Jones potential and an electrostatic term with
a distance-dependent dielectric ε=4r and a cutoff of 8 Å. Structures
were analysed with InsightII, MOLMOL and PROCHECK-NMR
programs.
3. Results and discussion
3.1. Cell membrane integrity and cytotoxicity
A prerequisite for a peptide to be a potential CPP is that it is not
toxic towardsmammalian cells. Cytotoxicity was assayed on CHO cells
by measuring the number of viable cells and cell membrane integrity
was assayed by quantifying LDH leakage after incubation with
peptide. Concentrations from 0.1 to 20 μM of peptide (corresponding
to the range of concentrations employed for internalisation studies)
were used. Incubation times ranged from 1 to 24 h. None of the three
Fig. 1. Quantiﬁcation of internalised and membrane-bound peptide in CHO-K1 and
CHO-pgsA 745 cells at 37 °C and 4 °C. (A) Internalised peptide (pmol) or intracellular
concentrations (μM) of RL9 (left), RW9 (middle) and R9 (right) into CHO-K1 at 37 °C
(black) and 4 °C (dark grey) and into CHO-pgsA 745 at 37 °C (light grey) and at 4 °C
(white) (n≥8). (B) Membrane bound peptide (pmol) of RL9 (left), RW9 (middle) and
R9 (right) on CHO-K1 at 37 °C (black) and 4 °C (dark grey) and on CHO-pgsA 745 at
37 °C (light grey) and at 4 °C (white) (n≥4). Signiﬁcance was tested using a Welch's
corrected t test (ns: pN0.05, *0.05NpN0.01, **0.01NpN0.001, ***0.001Np).
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tion even at the highest peptide concentration (20 μM) and longest
incubation time (24 h) tested (data not shown).
3.2. Antimicrobial activity
Since several CPPs show antimicrobial activity [20] and share some
common features with antimicrobial peptides [12], the antimicrobial
activities of RL9, RW9 and R9 were assayed against two bacterial
strains: E. coli (Gram-negative) and S. aureus (Gram-positive). RL9
and R9 showed no activity against either strain, even at the highest
tested concentration (100 μM). On the other hand, RW9 proved to
have mild antimicrobial activity (Table 1). When incubated with
100 μM of RW9 for 24 h, 99% of S. aureus growth was inhibited. On
E. coli, at a concentration of 25 μM RW9, 99% of growth was inhibited
after 24 h incubation. Furthermore, the bacteria were able to re-grow
after being incubated with RW9 at 25 μM and 50 μM, showing that
RW9 is bacteriostatic but not bacteriolytic against E. coli. We did not
test whether RW9 was bacteriolytic or bacteriostatic against S. aureus
as the MIC (100 μM) is not biologically relevant.
Membranes of bacteria and eukaryotic cells differ in many aspects,
amongst which their lipid composition. Eukaryotic cell membranes
contain essentially zwitterionic lipids such as phosphatidylcholine
lipids (PC) whereas bacterial membranes are rich in negatively
charged lipids such as phosphatidylglycerol lipids (PG). As will be
shown in Sections 3.4 and 3.5, RL9, RW9 and R9 mainly interact with
anionic lipids and for that reason these peptides could potentially
have had antimicrobial activity. Indeed, most antimicrobial peptides
act against bacteria by disrupting (lysis, pore formation...) the
negatively charged bacterial membrane [21,22].
3.3. Quantiﬁcation of internalised and membrane-bound peptide
The quantiﬁcation of internalised and membrane-bound RL9 and
RW9 was performed using two cell lines: wild type CHO-K1 cells and
heparan sulphate (HS) and chondroitin sulphate (CS) proteoglycan-
deﬁcient CHO-pgsA 745 cells. This allowed us to study the role of
these proteoglycans in the internalisation and membrane binding
processes. Furthermore, the experiments were performed at two
temperatures: 37 °C and 4 °C. At 4 °C peptides can only enter the cell
through direct translocation, since endocytosis, an energy-dependent
process, is inhibited this temperature. The cellular uptake and
membrane-bound peptide quantiﬁcation experiments for R9 and
RW9 had already been performed by the same method [10]. They
were not repeated for R9, but they were in the case of RW9 as the N-
terminal tag was different.
3.3.1. Quantiﬁcation of internalisation
Internalisation studies have already showed that RW9 is a very
efﬁcient CPP [9,10]. Our results, which are displayed in Fig. 1,
conﬁrmed this observation. At 37 °C, RW9 was internalised to an
intracellular concentration of 10 μM in CHO-K1 cells, which makes it,
together with R9, one of the most efﬁcient known CPPs. In CHO-pgsA
745 cells, RW9 was still internalised, but to a lesser extent than in
CHO-K1 cells (around 4 μM) suggesting that cell surface HS and CS
play a role in the internalisation. At 4 °C, RW9 was still able to enter
both cell types, showing that RW9 has the ability to translocate
directly through the lipid bilayer. Direct translocation of an arginine-Table 1
Minimum inhibitory concentrations (bacteriostatic) determined for RL9, RW9 and R9
against Gram−E. coli and Gram+S. aureus.
MIC (μM) RL9 RW9 R9
E. coli N100 μM 25 μM N100 μM
S. aureus N100 μM 100 μM N100 μMtryptophan peptide, R7W, had already been reported, together with
penetratin and R7 [23]. On the other hand, RL9 was extremely poorly
internalised (approximately 0.5 μM) in CHO-K1 cells as well as CHO-
pgsA 745 cells, and was hardly detectable inside the cells. As a
comparison, R9 is as successfully internalised by CHO-K1 and CHO-
745 cells as RW9 at 37 °C. However, R9 is internalised to higher
amounts at 4 °C than RW9, showing that R9 translocates more
efﬁciently through the lipid bilayer. So oligoarginine peptides enter
cells both by direct translocation and endocytosis, in agreement with
previous studies from other laboratories [23–26].
At 37 °C, the amount of internalised peptide corresponds to a
fraction internalised by endocytosis and a fraction internalised by
direct translocation. At 4 °C, only direct translocation occurs.
Assuming that the fraction internalised via direct translocation at
37 °C is similar to the amount internalised at 4 °C, it is possible to
distinguish between the amount of peptide that entered the cells by
endocytosis and by translocation at 37 °C. In wild-type cells, RW9was
mainly internalised via endocytosis (80%), whereas in glycosamino-
glycan-deﬁcient CHO-pgsA 745 cells, direct translocation accounted
for 45% of the total internalised peptide. The situation is even more
accentuated for R9, where only translocation (and no endocytosis)
occurs in the glycosaminoglycan-deﬁcient cells. Therefore, HS and CS
proteoglycans appear to be important for the endocytosis mechan-
isms of CPPs uptake as was already shown by our laboratory [10].
However, in the absence of these proteoglycans, RW9 is still able to
internalise by endocytosis, showing that this peptide uses many
distinct pathways (translocation, glycosaminoglycan-dependent and
independent endocytosis) to enter cells.
3.3.2. Quantiﬁcation of membrane-bound peptide
RL9 and RW9 bound to the cell membrane of both cell lines,
however RL9 bound to a lesser extent than RW9. For these two
peptides, the presence or absence of the proteoglycans at the cell
surface seemed to have little effect on their binding to the membrane.
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seemed to bind less than at 37 °C. The behaviour of R9 was quite
different: it bound to the same extent to the cell membrane as RW9 at
37 °C, however, at 4 °C, the amount of bound peptide increased almost
three fold.
Overall, the results indicate that the three peptides are able to bind to
membranes independently of proteoglycans. At 4 °C, the amount of
RW9 and R9 bound to the membrane is higher than at 37 °C. This could
be a consequence of the inhibition of cell-membrane trafﬁcking over the
1 h incubation time [10]. Binding to the cell surfacewould therefore be a
purely physical process. R9 would accumulate the most at the cell
membrane, followed by RW9 and RL9. Since R9 has more charges than
RW9 and RL9, electrostatic interactions between the peptide and the
lipids and proteoglycans at the membrane could be involved. But this is
not the only factor at stake, since RL9 has the same amount of charges as
RW9 and binds considerably less to the membrane. Interestingly, a
parallel can be drawn with the peptide afﬁnities for lipid vesicles that
were determined using ITC (see Section 3.4).
Regarding the cellular uptake, it was quite unexpected that RW9
and RL9 have very different behaviours. One could think that the
tryptophan residues play an important role for internalisation as seen
in the case of penetratin, where the replacement of Trp 48 or 56 is
deleterious for cellular uptake [2,27] and greatly decreases the
peptide's partitioning into octanol [28]. However, tryptophan residues
are certainly not essential given that R9 internalises to the same
extent as RW9. Nonetheless, the tryptophan residues seem to be
important in the case of RW9 as compared to RL9. At this point, we
hypothesised that the different uptake behaviour of RW9 and RL9
might be explained from their different structures in contact with
lipids and distinct modes of interaction and reorganisation of the lipid
bilayer leading us to carry out the biophysical studies described
below.Fig. 2. DSC thermograms illustrating the effect of the addition of RL9, RW9 and R9 to DMPC
(1 mg/mL). The curves correspond to pure lipid and peptide to lipid ratio of 1:100, 1:50, 1:25
The curves correspond to pure lipid and peptide to lipid ratio of 1:100, 1:50, 1:25 and 1:103.4. DSC experiments
3.4.1. Effect of RL9, RW9 and R9 on the thermotropic behaviour of
anionic and zwitterionic lipids
Herein, we chose to use the C14 acyl chains lipids dimyristoyl
phosphatidylcholine (DMPC) and dimyristoyl phosphatidylglycerol
(DMPG). Regarding the headgroups, phosphatidylcholine is the major
component of eukaryotic cell membranes and therefore constitutes a
good model for this system. The external leaﬂet of eukaryotic cell
membranes also possesses anionic lipids such as phosphatidic acid
(PA), phosphatidylinositol (PI) and phosphatidylserine (PS) (at very
low levels) [29]. Phosphatidylglycerol (PG) was chosen as a rep-
resentative of anionic lipids in membranes to investigate the role
of electrostatic interactions between the peptide and the lipids.
Eukaryotic cell membranes are rich in unsaturated fatty acids. How-
ever, since the phase transition of these lipids is below 0 °C, it cannot
be monitored by DSC (the instrument only works above 0 °C). C14
fatty acid chain lipids were chosen because the phase transition of
these lipids occurs at room temperature which facilitates handling
and study of their phase transition by DSC. Even if this lipid is not a
major constituent in cell membranes, it has been widely employed to
follow the effects of peptides on lipid phase transitions (see [30] for
instance).
Thermograms illustrating the effect of RL9, RW9 and R9 on the
thermotropic phase behaviour of DMPC and DMPG MLVs are
presented in Fig. 2 and the corresponding thermodynamic parameters
are provided in Tables 2–4. Aqueous dispersions of DMPC and DMPG
both present two distinct endothermic transitions: a less energetic
event around 13 °C corresponding to the transition from the Lβ' gel
phase to the Pβ' ripple phase and a more energetic event around 24 °C
corresponding to the transition between the Pβ' ripple phase to the Lα
ﬂuid phase.and DMPG vesicles. (A) Addition of RL9 (left), RW9 (middle) and R9 (right) to DMPC
and 1:10. (B) Addition of RL9 (left), RW9 (middle) and R9 (right) to DMPG (1 mg/mL).
.
Table 2
Thermodynamic parameters obtained by DSC for the interaction of RL9 with MLVs of
DMPC, DMPG and DSPG.
Lipid P/L Tm
(°C)
ΔHm
(kcal/mol)
ΔT1/2
(°C)
Tpre
(°C)
ΔHpre
(kcal/mol)
DMPC 0 23.3 6.7 0.8 12.5 0.8
1/25 23.7 7.5 0.7 13.8 1.1
DMPG 0 22.4 6.4 0.9 10.4 0.3
1/25 21.9 7.3 0.9 – –
DSPG 0 52.4 14.0 0.9 – –
1/25 54.0 17.8 1.2 – –
Table 4
Thermodynamic parameters obtained by DSC for the interaction of R9 with MLVs of
DMPC, DMPG and DSPG.
Lipid P/L Tm (°C) ΔHm (kcal/mol) ΔT1/2 (°C) Tpre (°C) ΔHpre (kcal/mol)
DMPC 0 23.2 6.7 0.6 12.6 0.7
1/25 23.2 8.0 0.7 12.2 0.7
DMPG 0 21.7 6.7 0.8 9.4 0.32
1/25 21.6 6.9 0.9 – –
DSPG 0 50.2 13.7 1.0 – –
1/25 53.8 18.1 0.9 – –
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or the main transition of DMPC very slightly. In particular, it should be
noted that none of the three peptides abolished the pre-transition.
This indicates that these peptides do not interact with the polar
zwitterionic headgroups of DMPC. The effect of RL9 and RW9was also
tested on another zwitterionic lipid, dimyristoyl phosphatidyletha-
nolamine (DMPE) (data not shown) and no signiﬁcant interaction
could be observed, suggesting that the electrostatic interaction
between the lipid and the peptide is crucial. This observation is
further discussed in Sections 3.5 and 3.7.
In the case of DMPG, RL9 did not affect the main transition, but the
pre-transition disappeared at P/L 1/100. This shows that the peptide
only interacts with the lipid headgroups affecting its tilting without
affecting the fatty acid chain packing. The interaction of RW9 with
DMPG also lead to large changes in the thermotropic behaviour of the
lipid with reduction in the phase transition temperature (Tm), the
cooperativity and the enthalpy of the pre-transition (which disap-
pears at P/L 1/50). The decrease followed by the disappearance of the
pre-transition shows that RW9 interacts with the negatively charged
headgroups of DMPG. Decrease in Tm implies that RW9 interacts more
favourably with the ﬂuid phase of the lipid rather than with the gel
phase. The alteration of the enthalpy of the main transition and the
broadening of the peak suggest that the peptide is able to insert into
the hydrophobic core of the bilayer and interact with the hydro-
carbonated chains of the lipids. A similar trend was observed for R9.
At P/L 1/10 the thermogram often deviated from the trend
observed from P/L 1/100 to 1/25,at this very high peptide concentra-
tion other phenomena, such as precipitation, may occur and thus
these results will not be discussed here.
The eukaryotic cell membrane is composed of regions of different
thicknesses. In order to probe the role of the lipid hydrocarbonated
chains length in the peptide/lipid interactions, the effect of RL9, RW9
and R9 on the C18 acyl chains distearoyl phosphatidylglycerol (DSPG)
lipid was tested (Tables 2–4). Due to the pre-transition of DSPG being
very close to the main transition [31], it was not possible to study it
separately from the main transition. Generally, addition of peptide to
DSPG did not have exactly the same effect on the phase transition as
for DMPG. For all three peptides, an increase in Tm was observed,
together with small variations in enthalpy. Generally, perturbations in
the thermogram were weaker for DSPG when compared to DMPG,
probably due to the increase in Van der Waals interactions with chainTable 3
Thermodynamic parameters obtained by DSC for the interaction of RW9 with MLVs of
DMPC, DMPG and DSPG.
Lipid P/L Tm (°C) ΔHm (kcal/mol) ΔT1/2 (°C) Tpre (°C) ΔHpre (kcal/mol)
DMPC 0 23.3 6.3 0.8 10.0 0.6
1/25 23.1 8.0 0.6 12.6 0.9
DMPG 0 22.2 6.3 1.0 10.0 0.3
1/25 20.0 8.5 1.6 – –
DSPG 0 52.3 12.6 0.8 – –
1/25 53.3 8.9 0.8 – –length. The higher perturbation was observed in the case of RW9
probably due to its higher hydrophobicity (Tables 2–4) [28].
The thermodynamic parameters obtained from the DSC experi-
ments with RL9, RW9 and RW9 are summarised in Tables 2–4,
respectively, for the lipids alone and a peptide to lipid ratio of 1/25.
Overall, the results indicate that an electrostatic recognition
between the positively charged arginine residues of the peptides
and the anionic lipid headgroups is necessary for their interaction.
This correlates well with previous observations by Maiolo and
coworkers who reported that the binding of the R7 and R7W peptides
to lipid model systems depends strongly on lipid composition and
on the presence of negatively charged lipids [32]. When comparing
the peptides that are internalised by the cells (R9 and RW9) and
the peptide that is not internalised (RL9), the peptides that are
internalised promote an increase in the lipid bilayer ﬂuidity (decrease
of Tm)whereas the non-internalised peptide does not alter the ﬂuidity
of the bilayer (no change of Tm for RL9). Moreover RW9 and R9
perturb considerably more the cooperativity of the lipid phase
transition (signiﬁcant broadening of the transition peak) than RL9
due to a greater disruption of the interactions between the lipid fatty
acid chains induced by these peptides. The increase in the ﬂuidity of
the lipid bilayer by the R9 and RW9 peptides and subsequent greater
perturbation of the cooperativity of the lipid transition may be related
with their uptake properties. This will be further discussed below.
3.4.2. Effect of RL9 and RW9 on lipid membrane curvature
Addition of a peptide to a lipid membrane can induce modiﬁcation
in the curvature of the membrane. Changes in curvature are often
involved in lipid reorganisation induced by membrane-active pep-
tides and are an important element to consider. Eukaryotic mem-
branes possess up to 10% of phosphatidylethanolamine (PE) in their
external leaﬂet and a small percentage of phosphatidic acid [29].
Both lipids have a small headgroup and have tendency to induce a
negative curvature in membranes [33,34]. This can be investigated by
observing the shift in transition temperature TH from the lamellar Lα
ﬂuid phase to the hexagonal phase HII of PE lipids. Indeed, a shift of TH
to lower temperature when adding the peptide shows that the
apparition of the hexagonal phase is favoured, whereas a shift of TH to
higher temperature indicates that the peptide disfavours a negative
curvature.
The effects of RL9, RW9 and R9 on membrane curvature were
studied by observing the thermotropic behaviour of dipalmitoleoyl
phosphatidylethanolamine (DiPoPE) with or without peptide. DiPoPE
is a standard lipid often used because it displays the most energetic Lα
to HII transition amongst PE lipids [35]. However, as the lamellar to
hexagonal transition of DiPoPE is still quite low in energy, a high
concentration of lipid had to be used. The TH in the absence of peptide
was around 42 °C. Addition of RL9 to the lipid had little effect on the
TH. On the other hand, addition of RW9 induced a large shift of TH
to higher temperatures (50 °C) showing that the presence of RW9
strongly disfavours a negative curvature on the lipid membrane.
Finally, addition of R9 to DiPoPE slightly decreased the transition
temperature to 40.3 °C, R9 would then favour a negative curvature of
the bilayer (Fig. 3). These data indicate that RL9 does not affect the
Fig. 3. DSC thermograms illustrating the effect of the addition of RL9, RW9 and R9 to
DiPoPE (10 mg/mL). The peptides are added to reach the peptide to lipid ratio of 1:25.
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upon peptide addition due to peptide intercalation between the fatty
acid chains were not quantiﬁed because of their small magnitude.
3.5. Binding of RL9, RW9 and R9 to large unilamellar vesicles (LUVs)
The interaction of the three studied peptides RL9, RW9 and R9
with phospholipids was also investigated using ITC. The experiments
were performed as described by Seelig [36], large unilamellar vesicles
of DSPG were injected into the calorimeter cell containing the pep-
tide at 25 °C. From this, the enthalpy of binding of the peptide to
the liposome (ΔH) was determined as well as an apparent KA which
represents the afﬁnity of the peptide for the liposome and the
stoichiometry of binding n, i.e. the number of phospholipids per
peptide. The dissociation constant KD, the Gibbs free enthalpy (ΔG)
and the entropy (ΔS) of binding were derived from the KA and ΔH.
The binding isotherms are presented in Fig. 4, and the resulting
thermodynamic parameters are given in Table 5. For the three pep-
tides, binding to DSPG was an exothermic process and therefore,
enthalpy driven. RW9 and R9 had a high afﬁnity for the liposome
whereas RL9 had a much lower afﬁnity. This correlates well with the
membrane-bound peptide quantiﬁcation reported in Section 3.3, with
R9 and RW9 binding more to the cell membrane than RL9. A strongFig. 4. Isothermal titration of RL9 (A), RW9 (B) and R9 (C) with DSPG LUVs at 25 °C. The low
lipid/peptide molar ratio. The solid lines represent the best ﬁts to experimental data. Thermafﬁnity for liposomes of an arginine-rich peptide containing a
tryptophan residue, R7W, has also already been reported [32]. Finally,
the stoichiometry of binding for R9 was higher, which is consistent
with the fact that R9 bears more positive charges than RW9 and RL9.
The interaction between RW9, RL9 and R9 with distearoyl phospha-
tidylcholine (DSPC) liposomes was also investigated, but no binding
between the peptides and the liposomes could be observed (results
not shown). These results indicate that electrostatic interactions
between the positively charged arginines in the peptide and the
negatively charged phospholipids headgroups are essential for the
peptide/lipid recognition. When considering eukaryotic cell mem-
branes, it should be noted that they do not contain PG, but contain
other anionic lipids in the external leaﬂet of the membrane such as
small quantities of PS, PA and PI. Even if they are present at very low
levels, these negatively charged lipids contribute to the overall charge
of the eukaryotic membrane. They also promote high local concentra-
tions of peptide at the cell surface. Moreover, although we have not
investigated this aspect, several studies have shown a high afﬁnity of
basic peptides to HS, demonstrating the important role of electrostatic
interactions in the peptide/membrane recognition [37,38].
3.6. Changes in LUV turbidity induced by peptide addition
Turbidity experiments (Fig. 5) showed the changes of optical
density of suspensions of DMPC or DMPG LUVs with gradual addition
of peptide measured at 436 nm. Addition of RL9, RW9 or R9 to DMPC
LUVs caused no changes in turbidity, whereas it caused a massive
increase in the turbidity of the DMPG LUVs indicating that vesicle
aggregation takes place. This experiment was also important to
understand possible ﬂuctuation in the structure content of the
peptides observed by CD (see below). Indeed, a decrease of secondary
structure content was observed when increasing the peptide
concentration which can be attributed to a diminution of soluble
peptide due to precipitation. We also tried to monitor the size of the
aggregates formed after addition of peptide into LUVs suspension by
Dynamic Light Scattering (DLS), however, the polydispersity was too
high to allow us to draw signiﬁcant results from these experiments.er curves represent the heat of reaction (measured by peak integration) as a function of
odynamic parameters calculated from these experiments are presented in Table 5.
Table 5
Thermodynamic parameters of peptides binding to DSPG LUVs determined by ITC at
25 °C.
RL9 RW9 R9
KA
app (M−1) 7.2 104 10.5 105 8.8 105
KD
app (μM) 13.9 0.95 1.14
ΔH (kJ/mol) −0.46 −2.32 −0.39
ΔG (kJ/mol) −37.7 −44.3 −43.9
ΔS (kJ/mol/K) 0.12 0.14 0.15
Binding stoichiometry, n 8.3 6.4 13.1
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presence of lipids by CD
Usually unstructured in aqueous buffer, numerous membrane
active peptides tend to adopt a well-deﬁned secondary structure
when in contact with lipid membranes. This change in structure can
partly explain their membranotropic abilities. In some cases, peptide
structuring can even trigger cellular uptake [39]. CD spectroscopy was
used to determine the secondary structure of RL9, RW9 and R9 in
buffer as well as in presence of zwitterionic and negatively charged
bilayers, namely DMPC and DMPG LUVs. Results are displayed in
Fig. 6. Qualitative secondary structure assignments were based on the
following: α-helix, minima at 208 and 222 nm, maximum at 190 nm;
β-sheet, minimum at 218 nm, maximum at 195 nm; random coil,
minimum at 198 nm, no positive peak [40].
In buffer conditions, RL9 tended to be mainly unstructured. This
was also the case when the peptide was in the presence of DMPC
LUVs. However, in the presence of DMPG, the peptide gained an α-
helical structure as indicated by the two clear minima at 208 nm and
222 nm on the spectrum. Therefore, RL9 is able to adopt a helical
amphipathic structure only in the presence of negative charges. RW9
had partial helical content in buffer, and its secondary structure was
not sensibly modiﬁed in the presence of DMPC. Indeed, a slight
minimum at 222 nm can be observed on the corresponding spectra.
However, in the presence of DMPG, the CD signature changed sig-
niﬁcantly, with two deep minima appearing at 205 nm and 228 nm
and a maximum at 215 nm. This unusual spectrum likely arises from
the presence of the tryptophan residues interacting with the peptide
backbone or stacking [41], but no deﬁnite structure can be attributed.
Such signals were reported in the literature for the tryptophan-rich
antimicrobial peptides indolicidin and tritrypticin and were inter-
preted as beta turn structures [42–44]. However these tryptophan-
rich peptides contain proline residues which are consistent with such
a structure as opposed to RW9 which only contains arginine and
tryptophan residues. Therefore, the structure of RW9 in the presence
of DMPG could not be easily determined using CD spectroscopy and
was further investigated using NMR. Since NMR experiments cannot
be performed with liposomes which are too large objects, we
employed dodecyl phosphocholine (DPC), dioctanoyl phosphatidyl-
glycerol (D8PG) and sodium dodecyl sulfate (SDS) as model systems
(the reason for the choice of those molecules is provided below).Fig. 5. Turbidity changes induced by addition of RL9 (squares), RW9 (dots) and R9
(diamonds) to DMPC (hatched line) and DMPG (solid line) LUVs.Therefore, CD spectra of RW9 and RL9 in the presence of such model
systems were also recorded (Fig. 7). In the presence of SDS RW9
was structured in α-helix, whereas in the case of DPC there was a
mixture of helical structures with the signal typical of tryptophan-rich
peptides. The tryptophan contribution to the CD signal became more
intense in the case of D8PG, similarly to what was observed with
DMPG.
R9 was mostly unstructured in solution and in the presence of
DMPC but became partly structured in the presence of DMPG with a
CD signal close to an α-helix signal. However the signal is not the
signature of a pure helix since the minima are not at 208 and 222 nm
but are slightly shifted towards 205 and 220 nm, indicating the
presence of other states such as random coil conformation [45]. These
small displacements of the absorbance minima were also observed in
the case of RW9 in buffer and with DMPC.
These observations show that in our studies structuring of the
peptide in the presence of lipids is not directly linked to its biological
properties. It is interesting to see that RL9 gains an amphipathic
helical structure in the presence of negatively charged lipids but is
neither a CPP nor an antimicrobial peptide. As regards to RW9, the
situation is more complicated as the CD data could not provide uswith
a deﬁnite structure for this peptide.
3.8. Peptides secondary structure determination in presence of
membrane-mimetic systems by NMR
Since the CD spectra of RW9 exhibited atypical signatures, the
conformations of RW9 and RL9 peptides were further investigated by
NMR spectroscopy in aqueous and in micellar solutions. Proton
sequence-speciﬁc resonance assignments were obtained using stan-
dard procedures based on the analysis of homonuclear 2D TOCSY
(through bond) and 2D NOESY (through space) correlation experi-
ments. Natural abundance 2D 1H-13C HSQC spectra was also recorded
to facilitate side-chain assignments and provide additional confor-
mational parameters. Preliminary information on the peptide struc-
ture was ﬁrst inferred from the analysis of the chemical shift
deviations (CSDs) of 1Hα and 13Cα resonances. Indeed, these CSDs,
deﬁned as the differences between observed chemical shifts of each
amino acid and corresponding random coil values [46], are good
indicators of the local conformational propensities of each residue
[47].
The RW9 and RL9 peptides show little 1H, 13C chemical shift
dispersion and small CSDs of Cα resonances in aqueous solutions
(Fig. 8), indicative of random coil conformations. The upﬁeld shifts of
Hα resonances (average value of −0.2 ppm) observed in RW9 are
probably due to aromatic ring current effects of the three Trp residues,
since the CSDs of corresponding Cα resonances show near zero values.
Therefore the secondary structure analysis was mainly based on Cα
CSDs for this peptide. The absence of preferential conformations is
further conﬁrmed by the averaged values of 3JHN-Hα coupling con-
stants (~7 Hz), together with the pattern of intraresidual and se-
quential backbone NOEs: sequential Hαi–HNi+1 NOEs stronger than
intraresidual Hαi–HNi NOEs, weak sequential HNi–HNi+1 NOEs.
These results are in good agreement with the CD data.
3.8.1. RW9 peptide in micellar environments
The addition of DPC or SDS micelles causes a large chemical shift
dispersion of amide and aromatic resonances and a broadening of
resonances (Fig. S2), indicating that the RW9 peptide interacts with the
detergent micelles and undergoes signiﬁcant conformational changes.
The addition of D8PG micelles caused a precipitation of peptide–
detergent complexes, preventing the NMR study. The chemical shift
dispersion of 1H resonances is larger in DPC micelles than in SDS
micelles and the chemical shift changes of the indoleHNε1 protonsdiffer
in the two detergents, reﬂecting variations of environments for the Trp
residues. Continuous stretches of upﬁeld shifts of Hα resonances and
Fig. 6. CD spectra of RL9 (A), RW9 (B) and R9 (C) in 10 mM sodium phosphate buffer (solid line), DMPC LUVs (hatched line) and DMPG (dotted line) at P/L ratio of 1/25 measured at
20 °C.
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sequence, showing that the RW9 peptide adopts helical conformations
in the presence of detergents (Fig. 8). Assuminganaverage CαCSDvalue
of 2.6 ppm inhelices [47], the amount of helicitywas estimated to67% in
DPC and 27% in SDSmicelles. The smaller helix content observed in SDS
is in agreement with the CD data. The Cα CSDs are smaller for the last
two residues of RW9 in DPC, indicating a loosening of the helix in the C-
terminal part. The helix adopted by RW9 in the anionic SDS detergent is
less stable, residues in the N-terminal half showing the highest helical
propensity. The helical conformation of RW9 peptide is further
supported by the pattern of intraresidual and sequential NOEs observed
in both detergent systems, namely strong HNi–HNi+1 and Hαi–HNi
NOEs, and medium Hαi–HNi+1 NOEs, together with characteristic
medium-range Hαi–HNi+3 and Hαi–HNi+4 NOEs (Fig. 9).
Differences in the conformations of RW9 side-chains are also
observed in the two detergent systems, as revealed by NOEs involving
side-chain protons. In DPC micelles, numerous NOEs involving Trp
aromatic protons are observed, in particular with Arg side-chain
methylenic protons. This indicates the presence of persistent cation-π
interactions between Arg and Trp side-chains. In contrast, in SDS
micelles, the NOEs involving Trp aromatic protons are less numerous
and of weaker intensity.
The NMR structures of RW9 in both solvents were calculated by
restrained molecular dynamics in DYANA and reﬁned by energy
minimisation with XPLOR-NIH and CHARMM22 forceﬁeld (Fig. 10).
The rmsd calculated on backbone atom positions is 0.35 and 0.84 Å,
for the structures in DPC and SDS respectively. The peptides adopt
well-deﬁned amphipathic helices, with a large polar sector. The side-
chain conformations are better deﬁned in the family structure in DPC.
Cation-π interactions are observed in different conformers of the NMR
structure family in DPC. Especially, Arg8 residue was found to interact
preferentially with Trp4 and Trp7. This is in agreement with the
upﬁeld shifted resonances of its Hγ and Hδ protons, in comparison
with other Arg residues. The interactions observed between side-
chains slightly differ for the NMR structure ensemble in SDS. ThisFig. 7. CD spectra of RL9 (A) and RW9 (B) in the presence of DMPG (solid line), DPC (hatchresult is conﬁrmed by the analysis of Arg side chain chemical shifts,
residue Arg5 exhibiting the most upﬁeld shifted resonances. These
differences in side-chain interactions observed in zwitterionic and
anionic micelles, as revealed by NMR spectroscopy, enable us to re-
examine the CD data. Indeed, the large discrepancy in the CD spectra
in DPC and SDS micelles can be ascribed to different helical contents,
together with different orientations of Trp chromophores that can be
involved in π-π or π-cation interactions. The negative band at 228 nm
in the CD spectra is consistent with interactions between Trp side
chains [41,42]. This contribution is smaller in anionic SDS micelles,
which can be explained by less well deﬁned side chain orientations.
3.8.2. RL9 peptide in micellar environments
The RL9 peptide also adopts helical conformations in the presence
of DPC or SDS micelles, as shown by the CSDs (Fig. 8) and pattern of
NOEs (Fig. 9). The amount of helicity, as inferred by Cα CSDs, is 75% in
DPC and 53% in SDS. The CSDs of Hα protons yield close values of 75%
and 38% of helix in DPC and SDS, respectively, based on an average Hα
CSD value of 0.35 ppm in helices [47]. The helical propensity decreases
in the C-terminal part in both detergent systems. The NMR structure
of RL9 in DPC (Fig. 10) shows a well-deﬁned amphipathic helix for
residues 1–7, with a small hydrophobic sector and a larger polar
face. The characterisation of medium-range Hα–HN NOEs in SDS
was hampered by the very small chemical shift dispersion of Hα
resonances. Therefore structures were not calculated in SDS, due to
the short number of assigned medium-range NOEs.
4. Conclusions
Herein, we have studied the cell membrane binding and cell
uptake of three arginine-rich peptides: the classic R9 and two amphi-
pathic peptides with the same charge distribution composed of six
arginines and three leucines or three tryptophans, RL9 or RW9, re-
spectively. To distinguish between the peptide internalised by direct
translocation and by endocytosis, quantiﬁcation of peptide uptake byed line) and SDS (dotted line) at a peptide concentration of 50 μM, measured at 20 °C.
Fig. 8. 1Hα and 13Cα Chemical Shift Deviations (CSDs) of RL9 (A, C) and RW9 (B, D) peptides in sodium phosphate buffer (solid lines), in DPC micelles (solid grey lines) and in SDS
micelles (hatched grey lines).
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(translocation and endocytosis). Furthermore, to investigate the role
of HS and CS proteoglycans, the experiments were performed in cells
expressing (CHO-K1) or not (CHO-pgsA745) glycosaminoglycans at
their surface. We have shown that while R9 and RW9 internalise in
both cell lines, at 4 °C and 37 °C, RL9 does not, even if it binds slightly
to the cell membrane. The fact that RL9 does not internalise in cells is
very surprising since previous studies with a quite similar peptide
(RLRRLRRLRR) have shown that it is able to enter cells [48]. This
peptide possesses onemore arginine residue than RL9, but this should
not be sufﬁcient to explain differences in uptake between these two
sequences, since studies have shown that a minimum of six charges is
sufﬁcient for CPP internalisation [49,50]. These contradictory results
could be explained by the fact that quantiﬁcation of the cellular uptake
of the RLRRLRRLRR sequence was performed using Fluorescence-
activated cell sorting (FACS), which cannot distinguish between the
peptide that is bound to themembrane and peptide that is internalised
by cells, unlike the protocol using mass spectrometry quantiﬁcation
we applied in our study. Arginine-rich peptides being highly posi-
tively charged, they can bind strongly to membranes, moreover, the
guanidinium group has special afﬁnity for the polar headgroups of
phospholipids [28,51], and indeed,we have observed that RL9 binds to
the cell membrane. Washing the cells after incubation with peptide
may not be sufﬁcient to remove all membrane-bound peptides, andFig. 9. Diagram of backbone NOEs observed for RL9 in DPC micelles (A), and RW9 in DPC
horizontal bars of varying thickness. Solid lines correspond to unambiguously assigned NOproteolytic digestion of these extracellular peptides avoids subsequent
overestimation of the amount of internalisedpeptide. This is a valuable
example to show that extreme caution must be taken when analysing
CPP cellular uptake by ﬂuorescence methods with no external peptide
digestion or no ﬂuorescence quenching by Trypan blue [52] since the
presence ofﬂuorescence likely arises frompeptides that are just bound
to the membrane but not internalised [10].
In attempt to rationalise the different internalisation behaviour of
RL9 as compared to RW9 and R9, we investigated the interaction of
these peptides and their effects on the organisation of lipid membranes
using lipid model systems. Both R9 and RW9 are able to cross the cell
membrane via direct translocation, even though it is not the major
pathway for RW9. In any case, translocation or endocytosis, the cell
membrane is the ﬁrst obstacle that the peptide will encounter. Overall
our results demonstrate that the electrostatic interaction between the
peptides and lipids plays a major role as they lead to a decrease in the
Born energy barrier [28,51]. Independently from their structure, the
internalised peptides (R9 and RW9) have more afﬁnity for negatively
charged membranes than the peptide that is not internalised (RL9).
RW9 and R9 also increase the bilayer ﬂuidity and affect the fatty acid
chain packing more than RL9. An increase in the lipid bilayer ﬂuidity
renders the bilayer more prone to lipid supramolecular reorganisation
(e.g. formationof lipid domains,membrane bending and curvature) and
protein rearrangements occurring during peptide translocation and(B) or in SDS (C) micelles. The relative intensity of NOE connectivities is indicated by
Es and dotted lines represent ambiguous NOEs due to spectral overlap.
Fig. 10. 3D NMR structures of RL9 in DPC micelles (A), and RW9 in DPC (B) or SDS (C) micelles. Structures were superimposed by best ﬁtting of backbone atoms of residues 1–7.
Backbone atoms are shown in black. Side-chain atoms are shown in dark blue (Arg residues), green (Leu residues) or light blue (Trp residues).
392 A. Walrant et al. / Biochimica et Biophysica Acta 1808 (2011) 382–393endocytosis. This could partially explain the differences in uptake
observed between R9 and RW9 and RL9.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2010.09.009.
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